Sarcoidosis is a multisystemic granulomatous disease of uncertain etiology.
Several drugs have been linked to the development of sarcoidosis or systemic granulomatous reactions indistinguishable from this disease.
We present the clinical case of a patient diagnosed with breast cancer and undergoing treatment with capecitabine who, after developing systemic and musculoskeletal symptoms, was ultimately diagnosed with capecitabine-induced sarcoidosis.
